We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01611675
Recruitment Status : Terminated (Adverse Events)
First Posted : June 5, 2012
Last Update Posted : April 6, 2017
Sponsor:
Information provided by (Responsible Party):
Keith Flaherty, Massachusetts General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : January 2014
  Study Completion Date : January 2014